BE867410A - VACCINE AND INJECTION DOSE FOR IMMUNOTHERAPY OF NEOPLASTIC DISEASE - Google Patents

VACCINE AND INJECTION DOSE FOR IMMUNOTHERAPY OF NEOPLASTIC DISEASE

Info

Publication number
BE867410A
BE867410A BE187981A BE187981A BE867410A BE 867410 A BE867410 A BE 867410A BE 187981 A BE187981 A BE 187981A BE 187981 A BE187981 A BE 187981A BE 867410 A BE867410 A BE 867410A
Authority
BE
Belgium
Prior art keywords
immunotherapy
vaccine
neoplastic disease
injection dose
dose
Prior art date
Application number
BE187981A
Other languages
French (fr)
Original Assignee
Mccollester Duncan Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mccollester Duncan Lee filed Critical Mccollester Duncan Lee
Publication of BE867410A publication Critical patent/BE867410A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BE187981A 1978-04-20 1978-05-24 VACCINE AND INJECTION DOSE FOR IMMUNOTHERAPY OF NEOPLASTIC DISEASE BE867410A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89812278A 1978-04-20 1978-04-20

Publications (1)

Publication Number Publication Date
BE867410A true BE867410A (en) 1978-11-24

Family

ID=25408978

Family Applications (1)

Application Number Title Priority Date Filing Date
BE187981A BE867410A (en) 1978-04-20 1978-05-24 VACCINE AND INJECTION DOSE FOR IMMUNOTHERAPY OF NEOPLASTIC DISEASE

Country Status (11)

Country Link
JP (1) JPS54154506A (en)
AU (1) AU519008B2 (en)
BE (1) BE867410A (en)
DE (1) DE2822731A1 (en)
FR (1) FR2423223A1 (en)
GB (1) GB1603597A (en)
IE (1) IE47736B1 (en)
IN (1) IN149012B (en)
MX (1) MX5759E (en)
NL (1) NL7805501A (en)
PH (1) PH14990A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1100569C (en) * 1997-01-24 2003-02-05 石桂秀 Method for preparing tumour vaccinum

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2900184A (en) * 1983-06-10 1984-12-13 Richard F. Martin Membrane antigens generated from pooled cells and monoclonal antibodies
GB8321009D0 (en) * 1983-08-04 1983-09-07 New R R C Immunological compositions
DE19519492A1 (en) * 1995-05-27 1996-11-28 Miele & Cie Carrier for metal workpieces
WO2021046186A1 (en) * 2019-09-04 2021-03-11 Vcell Therapeutics, Inc. Vaccine for treatment of cancer and method of making by stress reprogramming
WO2025028658A1 (en) * 2023-08-03 2025-02-06 国立大学法人東京農工大学 Immunopotentiator and immunopotentiating method, and method for producing aggregate and/or assembly of protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065141A (en) * 1960-08-24 1962-11-20 Albert E Gessler Separation of nucleoproteins and nucleic acids from aqueous protein mixtures
DE1617865A1 (en) * 1966-03-12 1971-09-02 Karl Dr Med Theurer Process for the manufacture of anti-cancer drugs
GB1193378A (en) * 1967-04-11 1970-05-28 Rand Dev Corp Cancer Antigen Complexes
GB1291134A (en) * 1970-01-21 1972-09-27 Anvar A process for the production of mammal cell anti-sera
US4053586A (en) * 1971-10-08 1977-10-11 Intermountain Laboratories, Inc. Preparation for treating squamous cell carcinoma and method for making same
ZA782613B (en) * 1978-05-08 1979-12-27 D Mccollester Vaccine and method for immunotherapy of neoplastic disease

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1100569C (en) * 1997-01-24 2003-02-05 石桂秀 Method for preparing tumour vaccinum

Also Published As

Publication number Publication date
AU519008B2 (en) 1981-11-05
IE780974L (en) 1979-10-20
AU3605978A (en) 1979-11-15
FR2423223A1 (en) 1979-11-16
NL7805501A (en) 1979-10-23
IE47736B1 (en) 1984-06-13
JPS54154506A (en) 1979-12-05
FR2423223B1 (en) 1983-07-29
GB1603597A (en) 1981-11-25
MX5759E (en) 1984-06-28
DE2822731A1 (en) 1979-10-31
IN149012B (en) 1981-08-15
PH14990A (en) 1982-03-12

Similar Documents

Publication Publication Date Title
PT73828B (en) NOVEL AMINO-2-TRIFLUOROMETHOXY-6 BENZOTHIAZOLE MEDICINE
IT1130709B (en) IMPLANTABLE REGULATOR FOR THE INFUSION OF MEDICINAL SUBSTANCES
BE878688A (en) IMMUNOGLOBULIN-BASED PREPARATION CONTAINING ANTIBODIES FOR INTRAVENOUS INJECTION AND PROCESS FOR OBTAINING IT
FR2508318B1 (en) BANDAGE FOR THE ADMINISTRATION OF A PHARMACEUTICAL SUBSTANCE
FR2314731A1 (en) AZACYCLOALCAN-2-ONES 1-SUBSTITUTES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AS EXCIPIENTS
BE843140A (en) AAZACYCLOALCAN-2-ONES 1-SUBSTITUTES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AS EXCIPIENTS
FR2497661B1 (en) NEW MOLDED MEDICINE
SE8204873D0 (en) PHARMACEUTICAL PREPARATIONS, INCLUDING HUMAN INSULIN AND HUMAN C-PEPTIDE
IT1193348B (en) PHARMACEUTICAL COMPOSITION BASED ON THIAZOLIDIN-4-CARBOXYLIC ACID FOR THE TREATMENT OF NEOPLASTIC DISEASES AND PREPARATION METHODS
DK154607C (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF ERGOTAL KALOIDS
IT1111711B (en) DEVICE FOR THE SUPPLY OF A SINTERING MIXTURE
CH470479A (en) Method of preparing a vaccine
FR2300671A1 (en) DEVICE FOR THE INTRODUCTION OF INSERTION PARTS INTO THE CAVITES OF A MOLD
IT1096665B (en) PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF FRIGIDITY AND IMPOTENCE STATES
DE2963835D1 (en) Process for stabilisation of 4-methyl-5-(2'-chlorethyl)-thiazol
FR2535322B1 (en) PREPARATION OF AMINOCYCLOPENTANIC ACIDS
FR2332979A1 (en) SULFAMIC ACID HALOGENIDES AND THEIR PREPARATION
FR2317940A1 (en) METHOD OF PREPARING A VACCINE FOR THE TREATMENT OF CANCER
BE857794A (en) PIGLET OEDEMA DISEASE VACCINE
IT7967187A0 (en) DERIVATIVE OF 6 CAPROLACTAM FOR USE PROCEDURE TO OBTAIN A NEW PHARMACEUTICAL
FR2426737B2 (en) PROCESS FOR THE PREPARATION OF A TRUTH VHS VACCINE
BE854265A (en) MEDICINAL PRODUCT FOR THE TREATMENT OF PRIMARY AND SECONDARY HYPERLIPOROTEINEMIA
FI930097A7 (en) Dosage form for administering the drug for the implementation of daily therapy
NZ185768A (en) Method and vaccine for immunotherapy of neoplastic disease
JPS55122712A (en) Novel medicine state of oral drug and its manufacture

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MCCOLLESTER DUNCAN LEE

Effective date: 19870531